Novartis

Member

Novartis Sustainability Actions

Created ESG Reporting Council

Novartis created an ESG Reporting Council to review the quality of ESG data, current trends and emerging standards.

COVID-19 Drug Availability Program

Novartis made 15 drugs that treat key symptoms of COVID-19 available to low-income and lower-middle-income countries at zero profit.

About Novartis

  • Status
  • Unverified
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.